Get started
Author

Agrin Moeini

Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
2018 · Roser Pinyol, Robert Montal, et al. · Gut · 325
Massive parallel sequencing uncovers actionable FGFR2–PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma
2015 · Daniela Sia, Bojan Losic, et al. · Nature Communications · 311
PDF
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma
2020 · Robert Montal, Daniela Sia, et al. · Journal of Hepatology · 301
Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
2021 · Roser Pinyol, Sara Torrecilla, et al. · Journal of Hepatology · 249
PDF
Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade
2020 · Eduardo Bonavita, Christian P. Bromley, et al. · Immunity · 248
PDF
Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma
2015 · Agrin Moeini, Daniela Sia, et al. · Clinical Cancer Research · 241
Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies
2013 · D Sia, V Tovar, et al. · Oncogene · 236
Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy
2021 · Victoria S. Pelly, Agrin Moeini, et al. · Cancer Discovery · 226
Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
2015 · Victoria Tovar, Helena Cornella, et al. · Gut · 206
Emerging Signaling Pathways in Hepatocellular Carcinoma
2012 · Agrin Moeini, Helena Cornellà, et al. · Liver Cancer · 195
Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma
2017 · Sara Torrecilla, Daniela Sia, et al. · Journal of Hepatology · 182
Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity
2017 · Agrin Moeini, Daniela Sia, et al. · Journal of Hepatology · 174
Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations
2022 · Charlotte R. Bell, Victoria S. Pelly, et al. · Nature Communications · 136
PDF
IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models
2016 · Iris Martinez-Quetglas, Roser Pinyol, et al. · Gastroenterology · 130
An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents
2019 · Agrin Moeini, Sara Torrecilla, et al. · Gastroenterology · 92
PDF
Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials
2019 · Robert Montal, Carmen Andreu-Oller, et al. · British Journal of Cancer · 90
PDF
Cell of origin in biliary tract cancers and clinical implications
2021 · Agrin Moeini, Philipp K. Haber, et al. · JHEP Reports · 79
Gene Signatures in the Management of Hepatocellular Carcinoma
2012 · Yujin Hoshida, Agrin Moeini, et al. · Seminars in Oncology · 73
The Future of Patient-Derived Tumor Xenografts in Cancer Treatment
2015 · Daniela Sia, Agrin Moeini, et al. · Pharmacogenomics · 58
Circulating tumor DNA (ctDNA) in patients with muscle-invasive bladder cancer (MIBC) who received perioperative durvalumab (D) in NIAGARA.
2025 · Thomas Powles, Michiel Simon Van Der Heijden, et al. · Journal of Clinical Oncology · 46
PDF
Integration of genomic information in the clinical management of HCC
2014 · Iris M. Quetglas, Agrin Moeini, et al. · Best Practice & Research Clinical Gastroenterology · 23
Kinetic and structural evidence of the alkenal/one reductase specificity of human ζ-crystallin
2010 · Sergio Porté, Agrin Moeini, et al. · Cellular and Molecular Life Sciences · 20
Corrigendum to ‘Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis’ [J Hepatol 75 (2021) 865–878]
2021 · Roser Pinyol, Sara Torrecilla, et al. · Journal of Hepatology · 15
PDF
Novel alkenal/one reductase activity of yeast NADPH:quinone reductase Zta1p. Prospect of the functional role for the ζ-crystallin family
2011 · Eva Crosas, Sergio Porté, et al. · Chemico-Biological Interactions · 13
Why Does Every Hepatocellular Carcinoma Clinical Trial Using Molecular Targeted Agents Fail?
2012 · Ijin Joo, Byung Ihn Choi, et al. · Liver Cancer · 9
PDF
Works count: 120
Citation count: 3,705
H-index: 21
I10-index: 24
Year
Topic
Type